Alopecia Areata – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Alopecia Areata – Drugs In Development, 2024 report and make more profitable business decisions.
Alopecia areata is an autoimmune condition characterized by unpredictable, patchy hair loss. It occurs when the immune system mistakenly attacks hair follicles, leading to hair loss in small, round patches on the scalp or other parts of the body. In some cases, it can progress to total hair loss (alopecia totalis) or loss of hair on the entire body (alopecia universalis). The exact cause of alopecia areata is not fully understood, but it is believed to involve a combination of genetic, environmental, and autoimmune factors. It is thought that the immune activity leads to follicle shrinkage and the eventual interruption of hair growth. Alopecia areata typically presents as smooth, round patches of hair loss on the scalp. It can also affect other hair-bearing areas, such as eyebrows, eyelashes, or beard. In some cases, individuals may experience tingling or mild discomfort in the affected areas.
The Alopecia Areata drugs in development market research report provide comprehensive information on the therapeutics under development for Alopecia Areata, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alopecia Areata and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Alopecia Areata | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 46 molecules, with 46 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Alopecia Areata therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Alopecia Areata pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Alopecia Areata treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbbVie IncAccro Bioscience Suzhou Co Ltd
Akaal Pharma Pty Ltd
Aldena Therapeutics Inc
Arcutis Biotherapeutics Inc
Aslan Pharmaceuticals Ltd
BiologicsMD Inc
Bristol-Myers Squibb Co
CAGE Biosciences Inc
Chengdu Zenitar Biomedical Technology Co Ltd
Concert Pharmaceuticals Inc
E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
Epibiotech Co Ltd
Equillium Inc
Forte Biosciences Inc
HCell Inc
HCW Biologics Inc
Horizon Therapeutics Plc
Inmagene Biopharmaceuticals Ltd
JN Biosciences LLC
Longwood Biopharmaceuticals Co Ltd
Mallia Therapeutics GmbH
Maruho Co Ltd
Maxinovel Pharmaceuticals
Nektar Therapeutics
Nepsone ehf
Nextgen Bioscience
Ornovi Inc
Pfizer Inc
Phio Pharmaceuticals Corp
Q32 Bio Inc
Regeneron Pharmaceuticals Inc
Reistone Biopharma Co Ltd
Serpin Pharma LLC
Shenzhen Chipscreen Biosciences Co Ltd
Soterios Ltd
Sun Pharma Advanced Research Company Ltd
Sun Pharmaceutical Industries Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Throne Biotechnologies Inc
Tigo GmbH
VeraDermics Inc
Zura Bio Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Alopecia reports